Immunization and Vaccines for Children
Agency: Centers for Disease Control - NCIRD
- 93.268 -- Immunization Cooperative Agreements
Archived opportunityLast Updated: May 13, 2026
Important dates
- Archived: June 4, 2020
- Closed: May 5, 2020
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Award details
- Expected project funding: $377,277,423
- Expected awards: 64
Award min.
$0
Award max.
$0
- Funding opportunity number:CDC-RFA-IP19-1901
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: February 5, 2019
- Archive date: June 4, 2020
- Version: 5
Summary
Jump to documentsThe National Center for Immunization and Respiratory Diseases (NCIRD) is committed to the prevention of disease, disability, and death through immunization and by the control of respiratory and related diseases. NCIRD protects individuals and communities from vaccine-preventable disease through provision of federal funds and contracts to purchase and distribute vaccine, provision of technical and financial support of immunization programs, vaccine preventable disease surveillance, provider and public education, and evaluation.This cooperative agreement will support recipients with development, implementation, assessment, and promotion of immunization related activities with the goal of achieving and sustaining high immunization coverage, and with administration of the Vaccines for Children (VFC) and Section 317 vaccine program for eligible individuals and to maintain or improve response activities to vaccine preventable disease public health threats.
Eligibility
Government
- Special district governments
- City or township governments
- State governments
Miscellaneous
- Other
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| CDC-RFA-19-1901_UPDATE_4.20.2020_A_FINAL_002.pdf | CDC-RFA-IP19-1901 Final | Apr 20, 2020 07:04 PM UTC |
Link to additional information
No additional information is available
